Sale Alert!

Check out our latest deals! NEOPAR®


  Home > Farm Direct > Swine > Vaccines > Breeding >

Farrowsure Gold
Farrowsure Gold
Farrowsure Gold


 
FarrowSure GOLD is the newly approved vaccine for breeding stock that helps provide protection against porcine parvovirus (PPV), erysipelas and five strains of leptospirosis.
 
“Parvo, lepto, and erysipelas vaccination is an important component of any breeding herd health program,” says Steve Sornsen, DVM, MS, director of veterinary services for Pfizer Animal Health. “FarrowSure GOLD helps provide the longest labeled duration of erysipelas immunity available—18 weeks—for protection you can count on. And we have the manufacturing capacity to ensure a consistent, uninterrupted supply.”
 
The newly formulated FarrowSure GOLD aids in protecting healthy swine from breeding failure caused by porcine parvovirus (PPV), erysipelas caused by Erysipelothrix rhusiopathiae, and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona.
 
FarrowSure Gold has the advantage of a new, low-volume dose and are available in both 50-dose and 250-dose sizes.


Item# Item Name Our Price Qty Add
875-032415 Farrowsure Gold 250 dose
$234.99
875-032414 Farrowsure Gold 50 dose
$48.89
Check the items you wish to purchase, then click


Extended Information:

FARROWSURE® GOLD

Pfizer Animal Health

Parvovirus Vaccine

Killed Virus

Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For use in swine only

PRODUCT DESCRIPTION: FarrowSure GOLD is for vaccination of healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV), erysipelas caused by Erysipelothrix rhusiopathiae, and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona. An 18-week duration of immunity following vaccination has been demonstrated against erysipelas. FarrowSure GOLD is a liquid preparation of porcine parvovirus grown on an established porcine cell line, a serum-free, clarified E. rhusiopathiae culture, and whole cell cultures of the 5 Leptospira serovars identified above. The antigens have been chemically inactivated and adjuvanted with 2 adjuvants, including Amphigen®, to enhance the immune response.

DISEASE DESCRIPTION: PPV and Leptospira are common agents of reproductive loss in swine. While infection with either of these pathogens may produce subclinical disease, infection with PPV during pregnancy may result in fetal resorption, fetal mummification and stillbirths. Infection by Leptospira during the second half of pregnancy may cause abortions and stillbirths; late-term abortions are the most important economic effect of leptospirosis. Leptospirosis caused by any of the serovars represented here cannot be clinically differentiated. Abortions may also occur in sows infected with E. rhusiopathiae during pregnancy.

SAFETY AND EFFICACY: The safety of FarrowSure GOLD was demonstrated under field conditions in approximately 1,340 sows and gilts receiving single or multiple doses. No serious systemic or allergic reactions were observed following vaccination.

Efficacy of the fractions of FarrowSure GOLD was demonstrated in controlled challenge-of-immunity and immunogenicity tests. Additionally, duration-of-immunity studies demonstrated that FarrowSure GOLD protected pigs against E. rhusiopathiae challenge 18 weeks after the second vaccination.

DIRECTIONS:

General Directions: Shake well. Aseptically administer 2 mL intramuscularly.

Primary Vaccination: Healthy swine should receive 2 doses 3-5 weeks apart with the second dose administered 2-4 weeks prior to breeding. Healthy gilts, however, should receive the second dose as near as possible to 14 days prior to breeding.

Revaccination: Revaccination with a single dose is recommended prior to subsequent breedings. Boars should be revaccinated semiannually.

Good animal husbandry and herd health management practices should be employed.

PRECAUTIONS:

Store at 2°-7°C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.

Use entire contents when first opened.

Sterilized syringes and needles should be used to administer this vaccine.

Do not vaccinate within 21 days before slaughter.

Contains gentamicin as preservative.

Transient injection site swelling and/or inappetance may occur following vaccination.

As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.

This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

Technical inquiries should be directed to Pfizer Animal Health Veterinary Services, (800) 366-5288 (USA), (800) 461-0917 (Canada).

For veterinary use only

U.S. Veterinary License No. 189

Pfizer Animal Health, Exton, PA 19341, USA

Div. of Pfizer Inc, NY, NY 10017

50 doses

100 mL

85-0840-00

250 doses

500 mL

5248000

85-1206-00

NAC No.: 36902430




Share your knowledge of this product with other customers... Be the first to write a review

Browse for more products in the same category as this item:

Farm Direct > Swine > Vaccines > Breeding

Google+
Social Tab
Are you a fan of A to Z Vet Supply?
:like>
Hide Bar

Read our latest blog post...